Cytogenetics in multiple myeloma patients progressing into extramedullary disease
- 19 October 2015
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 97 (1), 93-100
- https://doi.org/10.1111/ejh.12688
Abstract
These data show that plasma cells harbor more aberrations during their transformation into extramedullary form.Keywords
Funding Information
- Czech Ministry of Health (NT 14575, NT 12130)
This publication has 38 references indexed in Scilit:
- Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide–bortezomib combinationsBritish Journal of Haematology, 2015
- Extramedullary Myeloma Spread Triggered by Surgical Procedures: An Emerging Entity?Acta Haematologica, 2014
- Positron Emission Tomography With Computed Tomography–Based Diagnosis of Massive Extramedullary Progression in a Patient With High-Risk Multiple MyelomaClinical Lymphoma Myeloma and Leukemia, 2013
- Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapseHaematologica, 2013
- Extramedullary multiple myelomaLeukemia & Lymphoma, 2012
- Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agentsHaematologica, 2012
- Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment ApproachJournal of Clinical Oncology, 2011
- Multiple MyelomaAnnual Review of Medicine, 2011
- Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patientsAnnals Of Oncology, 2009
- Plasmacytoma relapses in the absence of systemic progression post‐high‐dose therapy for multiple myelomaEuropean Journal of Haematology, 2005